Search
antineoplastic agent (chemotherapeutic agent)
Adverse effects:
- nearly all chemotherapeutic agents are associated with urticaria & morbilliform rash [1]
Notes:
- manufacturers have total price control of cancer drugs
- DrugAbacus can help physicians calculate what a cancer drug should cost
- ASCO proposed experiments in outcomes-based pricing of cancer drugs [2]
Related
chemotherapy
Specific
1-(2-choloroethyl)-3-(2,5-dioxo-3-piperidyl)-1-nitrosourea (PCNU)
2-chlorodeoxyadenosine (2-CdA) [cladribine] (Leustatin)
5-fluorouracil [5-FU] (Fluoroplex, Efudex, Adrucel, Carac)
6-mercaptopurine (Purinethol, 6-MP, Mecaleukin, Leukerin, Leupurin)
abarelix (Plenaxis)
abiraterone acetate (Zytiga)
alitretinoin (Panretin)
alkylating agent
alkylating agent combination
all-trans retinoic acid; tretinoin (Retin-A, Renova, Avita, Altreno, ATRA)
amcenestrant
antibiotic antineoplastic agent
antimitotic agent; mitotic inhibitor (antineoplastic agent)
antineoplastic combination (combination chemotherapy)
antineoplastic endocrine agent
antineoplastic enzyme inhibitor
antineoplastic immunomodulator
antineoplastic monoclonal antibody
antineoplastic photosensitizing agent
antineoplastic platinum complex; platinum-based chemotherapy
antineoplastic tyrosine kinase inhibitor
antineoplastic-adjuvant combination
antineoplaton
apalutamide (Erleada)
arsenic trioxide; As2O3 (Trisenox)
asparaginase (Elspar)
azacitidine; 5-azacytidine (Vidaza, Onureg)
Bacillus Calmette-Guerin (BCG, TheraCys, TICE, Pacis)
belagenpumatucel-L (Lucanix)
belinostat (Beleodaq)
belzutifan (Welireg)
bexarotene (Targretin)
BMS-354825
brentuximab vedotin (Adcetris)
buserelin (Suprecur)
cabazitaxel
calaspargase pegol-mkn (Asparlas)
capecitabine (Xeloda)
cedazuridine
cepharanthine
checkpoint inhibitor; immune checkpoint inhibitor; PD-1/PD-L1 inhibitor
clofarabine (Clolar)
CMP-001
cytosine arabinoside; cytarabine (Cytosar, ARA-C, HiDAC, Depocyt)
decitabine or 5-aza-2'-deoxycytidine
enzalutamide (Xtandi)
epothilone
eribulin mesylate (Halaven)
flavopiridol
floxuridine; fluorodeoxyurine; 2'-Deoxy-5-fluorouridine
fludarabine (Fludara)
GDC-0449
gemcitabine (Gemzar)
gilteritinib (Xospata)
gp100:209-217(210 M) peptide vaccine
idecabtagene vicleucel (Abecma)
imetelstat (Rytelo)
levamisole (Ergamisole)
metyrosine (Demser)
midostaurin (Rydapt)
mifamurtide (Mepact)
mitoxantrone (Novantrone, Mitozantrone)
mycophenolate (Cellcept, Myfortic)
nadofaragene firadenovec
nelarabine (Arranon)
nimustine (ACNU)
nirogacestat (Ogsiveo)
nocodazole
nogapendekin alfa inbakicept-pmln (Anktiva)
oblimersen (Bcl-2 antisense)
omacetaxine mepesuccinate; homoharringtonine (Synribo)
panobinostat (Farydak)
pegaspargase (Oncaspar, PEG-L-asparaginase)
pentostatin (Nipent, DCF, 2'deoxycoformycin)
plerixafor (Mozobil)
Polatuzumab Vedotin (POLIVY)
pralatrexate (Folotyn)
proxigermanium; propagermanium; Ge-132- carboxyethylgermanium sesquioxide; 2-carboxyethylgermasesquioxane
rabacfosadine (Tanovea)
radium Ra[223] dichloride (Xofigo)
radium-223
raltitrexed (Tomudex)
ramucirumab (Cyramza)
ricin
salinomycin; salinomycinum (Coxistac)
samarium [Sm-153] lexidronam
sintilimab
small inhibitory antineoplastic agent (ib drug)
strontium chloride
tafasitamab-cxix (Monjuvi)
tagraxofusp (Elzonris)
talimogene laherparepvec (Imlygic)
tazemetostat (Taxverik)
tebentafusp-tebn (Kimmtrak)
testolactone (Teslac, Fludestrin)
TG101348
tipiracil
tirapazamine (TPZ)
tirbanibulin (Klisyri)
tisagenlecleucel (Kymria)
topoisomerase inhibitor
trabectedin (Yondelis)
venetoclax (Venclexta)
verdinexor (Laverdia-CA1)
General
pharmaceutical agent
Properties
References
- Medical Knowledge Self Assessment Program (MKSAP) 16
American College of Physicians, Philadelphia 2012
- American Society of Clinical Oncology (ASCO) Position Statement
On Addressing the Affordability of Cancer Drugs.
June 1, 2017
http://www.asco.org/sites/new-www.asco.org/files/content-files/blog-release/documents/2017-ASCO-Position-Statement-Affordability-Cancer-Drugs.pdf
Component-of
antineoplastic-adjuvant combination